XXIV. Jahrestagung der Kind-Philipp-Stiftung für Leukämieforschung

Abolmaali, A

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Ackermann, S

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Armeanu-Ebinger, S

Sorafenib as a new therapeutic option for Hepatoblastoma

Macrophage-mediated cytotoxicity against rhabdomyosarcoma cells

Attarbaschi, A

Screening for the P2RY8-CRLF2 fusion gene in childhood acute lymphoblastic leukaemia

Bartram, CR

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Bartram, T

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Bender, S

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Benedikt, A

The AF4/AF4-MLL interactome

Berthold, F

Identifying treatment response in high-risk Neuroblastoma

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Beyerle, A

Targeted siRNA delivery to myeloid precursor cells

Blazar, BR

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Bohrer, A

Neuroblastoma develops from neural crest stem cells

Bomken, S

In acute lymphoblastic leukaemia stemness is frequent and ubiquitous

Bornschein, M

Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitro

Bourquin, JP

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Brackrock, D

Immunomodulation following treatment with ch14.18 and interleukin 2 in patients with refractory neuroblastoma

Breithaupt, P

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Brors, B

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Brummer, T

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Bueren, AO von

Prognostic role of p53 accumulation in patients with metastatic medulloblastoma (M +)

Bursen, A

Secondary mutations in t(4;11) leukemia

Cario, G

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Christiansen, H

Descriptive and functional analysis of amplified genome regions in primary human neuroblastoma and human neuroblastoma cell lines

Christiansen, NM

Descriptive and functional analysis of amplified genome regions in primary human neuroblastoma and human neuroblastoma cell lines

Cin, H

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Collins, VP

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

DePreter, K

Neuroblastoma develops from neural crest stem cells

Dewerth, A

Sorafenib as a new therapeutic option for Hepatoblastoma

Dingermann, T

Secondary mutations in t(4;11) leukemia

The AF4/AF4-MLL interactome

Functional inactivation of the AF4-MLL oncoprotein

Dittrich, T

Acetylation of p53 is involved in VPA induced death of AML cells

Eggert, A

Neuroblastoma develops from neural crest stem cells

Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitro

Ehemann, V

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Eicher, C

Sorafenib as a new therapeutic option for Hepatoblastoma

Eisenbraun, J

Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitro

Ellinghaus, E

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Emmrich, S

Characterization of miR-99a˜125b-2 polycistron in hematopoiesis and leukemogenesis

Engelbrecht, C

Functional inactivation of the AF4-MLL oncoprotein

Felsberg, J

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Fischer, M

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Fischer, S

Screening for the P2RY8-CRLF2 fusion gene in childhood acute lymphoblastic leukaemia

Fisher, J

Cysteine Proteases in acute myeloid leukaemia

Fisher, M

Identifying treatment response in high-risk Neuroblastoma

Flatley, A

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Franke, A

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Fruehauf, J

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Fuchs, J

Sorafenib as a new therapeutic option for Hepatoblastoma

Macrophage-mediated cytotoxicity against rhabdomyosarcoma cells

Fuka, G

Modulation of the p53 pathway by ETV6/RUNX1 in childhood ALL

Genschaft, M

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Gessi, M

Prognostic role of p53 accumulation in patients with metastatic medulloblastoma (M +)

Goidts, V

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Grausenburger, R

Glucocorticoid resistance may be implicated in the emergence of ETV6/RUNX1- positive relapses

Gruhn, B

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Hapke, M

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Harbott, J

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Hardtke-Wolenski, M

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Heidenreich, O

In acute lymphoblastic leukaemia stemness is frequent and ubiquitous

Cysteine Proteases in acute myeloid leukaemia

Targeted siRNA delivery to myeloid precursor cells

Heitmann, K

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Henke, K

Characterization of miR-99a˜125b-2 polycistron in hematopoiesis and leukemogenesis

Hennig, C

GATA1s exerts fetal stage-specific oncogenic effects in hematopoietic stem and progenitor cells

Herbst, J

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Hernaiz, P

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Hero, B

Identifying treatment response in high-risk Neuroblastoma

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Herr, R

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Herrmann, D

Macrophage-mediated cytotoxicity against rhabdomyosarcoma cells

Heukamp, L

Neuroblastoma develops from neural crest stem cells

Hofbauer, LC

Non-selective side effects of non-receptor tyrosine kinase inhibitors (TKI)

Hofmann, A

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Holfeld, E

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Hubertus, J

The role of DNA methylation at CTCF binding sites in the regulation of WT1 and NNAT in Wilms tumor

Hübner, T

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Huebener, N

Development of an IL-21 enhanced MYCN-DNA vaccine for anti-neuroblastoma immunotherapy

4-HPR (fenretinide) sensitizes human neuroblastoma cells for ch14.18-mediated NK cell and complement killing

Partial or multi drug resistant NB cell lines are highly sensitive towards chimeric receptor expressing NK-92-scFv(ch14.18)-zeta

Hummel, T

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Ikonomidou, C

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Ikonomidou, VN

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Inthal, A

Glucocorticoid resistance may be implicated in the emergence of ETV6/RUNX1- positive relapses

Jabado, N

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Jacob, K

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Jaeckel, E

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Janzarik, WG

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Joas, R

Screening for the P2RY8-CRLF2 fusion gene in childhood acute lymphoblastic leukaemia

Jones, DTW

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Kahlert, Y

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Kaindl, U

Modulation of the p53 pathway by ETV6/RUNX1 in childhood ALL

Kappler, R

The role of DNA methylation at CTCF binding sites in the regulation of WT1 and NNAT in Wilms tumor

Kirschbaum, C

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Klein, C

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Klusmann, JH

GATA1s exerts fetal stage-specific oncogenic effects in hematopoietic stem and progenitor cells

Functional Genomics: Identification of Potential Oncogenes on Chromosome 21 by RNA Interference Screening

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Acetylation of p53 is involved in VPA induced death of AML cells

Characterization of miR-99a˜125b-2 polycistron in hematopoiesis and leukemogenesis

Kocak, H

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Koch, ML

Functional Genomics: Identification of Potential Oncogenes on Chromosome 21 by RNA Interference Screening

Koestner, W

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Köhler, R

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

König, S

Non-selective side effects of non-receptor tyrosine kinase inhibitors (TKI)

Kontermann, R

Targeted siRNA delivery to myeloid precursor cells

Korshunov, A

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Kramm, P

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Krapf, G

Modulation of the p53 pathway by ETV6/RUNX1 in childhood ALL

Krone, F

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Kulozik, AE

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

Kuster, L

Glucocorticoid resistance may be implicated in the emergence of ETV6/RUNX1- positive relapses

Lambert, S

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Lee, DA

4-HPR (fenretinide) sensitizes human neuroblastoma cells for ch14.18-mediated NK cell and complement killing

Lefever, S

Neuroblastoma develops from neural crest stem cells

Li, Z

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Lichter, P

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Lindner, S

Neuroblastoma develops from neural crest stem cells

Lode, HN

Molecular characterization of a new anti-idiotype antibody for active immunotherapy in neuroblastoma

Development of an IL-21 enhanced MYCN-DNA vaccine for anti-neuroblastoma immunotherapy

Immunomodulation following treatment with ch14.18 and interleukin 2 in patients with refractory neuroblastoma

4-HPR (fenretinide) sensitizes human neuroblastoma cells for ch14.18-mediated NK cell and complement killing

Partial or multi drug resistant NB cell lines are highly sensitive towards chimeric receptor expressing NK-92-scFv(ch14.18)-zeta

Ludwig, WD

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Mann, G

Screening for the P2RY8-CRLF2 fusion gene in childhood acute lymphoblastic leukaemia

Maroz, A

GATA1s exerts fetal stage-specific oncogenic effects in hematopoietic stem and progenitor cells

Marschalek, R

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Secondary mutations in t(4;11) leukemia

The AF4/AF4-MLL interactome

Functional inactivation of the AF4-MLL oncoprotein

Maurer, J

Neuroblastoma develops from neural crest stem cells

Meissner, B

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Meyer, C

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Milde, T

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

Molenaar, J

Neuroblastoma develops from neural crest stem cells

Morak, M

Screening for the P2RY8-CRLF2 fusion gene in childhood acute lymphoblastic leukaemia

Modulation of the p53 pathway by ETV6/RUNX1 in childhood ALL

Möricke, A

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Müller-Höcker, J

The role of DNA methylation at CTCF binding sites in the regulation of WT1 and NNAT in Wilms tumor

Nebel, A

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Nürnberg, P

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Oberthuer, A

Identifying treatment response in high-risk Neuroblastoma

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Odenthal, M

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Oehm, C

Functional inactivation of the AF4-MLL oncoprotein

Omran, H

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Orkin, SH

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Pajtler, K

Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitro

Panzer-Grümayer, R

Screening for the P2RY8-CRLF2 fusion gene in childhood acute lymphoblastic leukaemia

Modulation of the p53 pathway by ETV6/RUNX1 in childhood ALL

Glucocorticoid resistance may be implicated in the emergence of ETV6/RUNX1- positive relapses

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Pfister, S

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

Pfister, SM

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Pietsch, T

Prognostic role of p53 accumulation in patients with metastatic medulloblastoma (M +)

Pleier, S

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Pless, B

Functional inactivation of the AF4-MLL oncoprotein

Plessow, F

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Pontan, F

Cysteine Proteases in acute myeloid leukaemia

Prall, S

Cysteine Proteases in acute myeloid leukaemia

Prelle, C

Secondary mutations in t(4;11) leukemia

Rasche, M

Characterization of miR-99a˜125b-2 polycistron in hematopoiesis and leukemogenesis

Rehe, K

In acute lymphoblastic leukaemia stemness is frequent and ubiquitous

Reifenberger, G

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Reinhardt, D

GATA1s exerts fetal stage-specific oncogenic effects in hematopoietic stem and progenitor cells

Functional Genomics: Identification of Potential Oncogenes on Chromosome 21 by RNA Interference Screening

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Acetylation of p53 is involved in VPA induced death of AML cells

Characterization of miR-99a˜125b-2 polycistron in hematopoiesis and leukemogenesis

Reker, D

Development of an IL-21 enhanced MYCN-DNA vaccine for anti-neuroblastoma immunotherapy

Remke, M

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Reynolds, CP

4-HPR (fenretinide) sensitizes human neuroblastoma cells for ch14.18-mediated NK cell and complement killing

Partial or multi drug resistant NB cell lines are highly sensitive towards chimeric receptor expressing NK-92-scFv(ch14.18)-zeta

Roels, F

Identifying treatment response in high-risk Neuroblastoma

Rößler, T

The AF4/AF4-MLL interactome

Rueger, R

Targeted siRNA delivery to myeloid precursor cells

Rutkowski, S

Prognostic role of p53 accumulation in patients with metastatic medulloblastoma (M +)

Ryzhova, M

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

Sabiani, S

Functional inactivation of the AF4-MLL oncoprotein

Sauer, MG

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Scheurlen, W

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Schmidt, M

Molecular characterization of a new anti-idiotype antibody for active immunotherapy in neuroblastoma

Scholz, A

Targeted siRNA delivery to myeloid precursor cells

Scholz, B

The AF4/AF4-MLL interactome

Schöning, J

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Schorle, H

Neuroblastoma develops from neural crest stem cells

Schramm, A

Neuroblastoma develops from neural crest stem cells

Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitro

Schrappe, M

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Schrauder, A

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Schreiber, S

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Schulte, JH

Neuroblastoma develops from neural crest stem cells

Schweinitz, D von

The role of DNA methylation at CTCF binding sites in the regulation of WT1 and NNAT in Wilms tumor

Seidel, D

4-HPR (fenretinide) sensitizes human neuroblastoma cells for ch14.18-mediated NK cell and complement killing

Partial or multi drug resistant NB cell lines are highly sensitive towards chimeric receptor expressing NK-92-scFv(ch14.18)-zeta

Seitz, G

Macrophage-mediated cytotoxicity against rhabdomyosarcoma cells

Shibina, A

4-HPR (fenretinide) sensitizes human neuroblastoma cells for ch14.18-mediated NK cell and complement killing

Partial or multi drug resistant NB cell lines are highly sensitive towards chimeric receptor expressing NK-92-scFv(ch14.18)-zeta

Siebert, N

Molecular characterization of a new anti-idiotype antibody for active immunotherapy in neuroblastoma

Development of an IL-21 enhanced MYCN-DNA vaccine for anti-neuroblastoma immunotherapy

Immunomodulation following treatment with ch14.18 and interleukin 2 in patients with refractory neuroblastoma

Smolka, MN

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Somanchi, S

4-HPR (fenretinide) sensitizes human neuroblastoma cells for ch14.18-mediated NK cell and complement killing

Speleman, F

Neuroblastoma develops from neural crest stem cells

Stanulla, M

In acute lymphoblastic leukaemia stemness is frequent and ubiquitous

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Starke, S

Descriptive and functional analysis of amplified genome regions in primary human neuroblastoma and human neuroblastoma cell lines

Stephan, H

Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitro

Stermann, A

Development of an IL-21 enhanced MYCN-DNA vaccine for anti-neuroblastoma immunotherapy

Sturm, D

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Suttorp, M

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Non-selective side effects of non-receptor tyrosine kinase inhibitors (TKI)

Tauer, JT

Non-selective side effects of non-receptor tyrosine kinase inhibitors (TKI)

Teigler-Schlegel, A

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

Thakur, BK

Gene expression-based chemical genomics identifies VPA to revert the oncogenic effect of GATA1s in Down syndrome leukemia

Acetylation of p53 is involved in VPA induced death of AML cells

Thangapandi, VR

Functional Genomics: Identification of Potential Oncogenes on Chromosome 21 by RNA Interference Screening

Thor, T

Neuroblastoma develops from neural crest stem cells

Till, S

Descriptive and functional analysis of amplified genome regions in primary human neuroblastoma and human neuroblastoma cell lines

Vandesompele, J

Neuroblastoma develops from neural crest stem cells

Versteeg, R

Neuroblastoma develops from neural crest stem cells

Vignali, DA

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Vormoor, J

In acute lymphoblastic leukaemia stemness is frequent and ubiquitous

Vorwerk, P

Morphological and neurocognitive sequelae following chemotherapy for leukemia in early childhood

Warmann, SW

Macrophage-mediated cytotoxicity against rhabdomyosarcoma cells

Weber, A

Descriptive and functional analysis of amplified genome regions in primary human neuroblastoma and human neuroblastoma cell lines

Wels, WS

Partial or multi drug resistant NB cell lines are highly sensitive towards chimeric receptor expressing NK-92-scFv(ch14.18)-zeta

Welte, K

D-L1 blockade effectively restores strong graft-versus-leukemia effects without graft- versus-host-disease after delayed adoptive transfer of T cell receptor gene-engineered allogeneic CD8+ T cells

Acetylation of p53 is involved in VPA induced death of AML cells

Westermann, F

Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma

Development of an IL-21 enhanced MYCN-DNA vaccine for anti-neuroblastoma immunotherapy

Wilson, K

In acute lymphoblastic leukaemia stemness is frequent and ubiquitous

Witt, H

SGK1: a novel prognostic marker and potential drug target in medulloblastoma

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Witt, O

Expression of the kinocilia marker gene WDR16: An indicator of favourable prognosis in pediatric ependymoma

FAM131B-BRAF Fusion Gene Resulting From 7q34 Deletion Leads to MAPK Pathway Activation in Pilocytic Astrocytoma

Zimmermann, M

Genome-wide associations of genetic variation with minimal residual disease in ETV6-RUNX1-positive childhood acute lymphoblastic leukemia

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Zitzmann, F

The role of DNA methylation at CTCF binding sites in the regulation of WT1 and NNAT in Wilms tumor

Zuzak, TJ

Viscum Album (mistletoe) extract inhibits growth of pediatric tumor cells in vitro